Search results
Merck KGaA to buy gene therapy tools maker for $600M
BioPharma Dive via Yahoo Finance· 1 day agoDive Brief: German drugmaker Merck KGaA agreed to buy Mirus Bio for $600 million to build expertise in a critical part of viral vector-based gene therapy...
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m
Pharmaceutical Technology via Yahoo Finance· 1 day agoMerck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive...
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 4 days agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda...
Why Top 4% Biotech Stock, Merus, Just Catapulted To A Record High
Investor's Business Daily· 33 minutes agoMerus stock catapulted to a record high Friday after its experimental regimen for head-and-neck...
Dow Jones Rises Ahead Of Inflation Report; AI Stock Workday Plunges On Earnings
Investor's Business Daily· 1 hour agoToday: Best Stocks To Watch Monday.com, Netflix and Nvidia chipmaker Taiwan Semiconductor...
Merck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 79%
Simply Wall St. via Yahoo Finance· 2 days agoKey Insights Institutions' substantial holdings in Merck implies that they have significant...
Fed Inflation Gauge, Key Earnings Highlight Investing Action Plan
Investor's Business Daily· 3 hours agoLate in the week, the Fed's favorite inflation gauge, the core PCE price index, will be on tap....
Merck & Co Inc (MRK) Sits And Waits For Direction At $131.30 Price – Stocks Register
Stocks Register· 1 day agoMerck & Co Inc (NYSE:MRK) at last check was buoying at $131.30 on Thursday, May 23 with a rise of 0.15% from its closing price on previous day. Taking a look at stock we notice ...
McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI
VentureBeat· 17 hours agoAtropos Health, a healthcare technology company focused on generating personalized real-world...
Merck KGaA Buys Mirus Bio for $600 Million
Market Watch· 1 day agoBy Ian Walker Germany's Merck KGaA is buying life-science company Mirus Bio for $600 million as it expands its life science business sector. The...